Look­ing to push check­point ef­fi­ca­cy, a qui­et mi­cro­bio­me up­start bags $67M for clin­i­cal work

Mi­cro­bi­ot­i­ca has some more funds to work with — $67 mil­lion more.

The qui­et mi­cro­bio­me ther­a­peu­tics spin­out with 48 em­ploy­ees an­nounced its Se­ries B ear­li­er this morn­ing, which was co-led by Swedish in­vestor Flerie In­vest along­side Chi­nese multi­na­tion­al con­glom­er­ate Ten­cent. Oth­er in­vestors hopped on­to the round, in­clud­ing new in­vestor British Pa­tient Cap­i­tal and ex­ist­ing in­vestors Cam­bridge In­no­va­tion Cap­i­tal, IP Group, and Sev­en­ture Part­ners.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER